| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.7M | -92.8% |
| R&D Expense | $134.9M | -39.4% |
| SG&A Expense | $59.4M | -11.6% |
| Operating Income | -$214.6M | -38.9% |
| Pre-tax Income | -$200.8M | -55.8% |
| Income Tax | $43.3M | +753.5% |
| Net Income | -$244.1M | -99.6% |
| EPS (Basic) | -$4.53 | -99.6% |
| EPS (Diluted) | -$4.53 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $307.5M | -34.8% |
| Current Assets | $315.2M | -35.1% |
| Total Assets | $326.8M | -40.3% |
| Current Liabilities | $40.8M | -15.8% |
| Total Liabilities | $46.3M | -23.0% |
| Stockholders' Equity | $280.5M | -42.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$163.6M | -9.0% |
| Investing Cash Flow | -$138K | +53.7% |
| Financing Cash Flow | -$139K | -108.9% |
| -99.6% |